Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Zoetis Total Liabilities 2011-2024 | ZTS

Zoetis total liabilities from 2011 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
  • Zoetis total liabilities for the quarter ending December 31, 2024 were $9.467B, a 1.85% increase year-over-year.
  • Zoetis total liabilities for 2024 were $9.467B, a 1.85% increase from 2023.
  • Zoetis total liabilities for 2023 were $9.295B, a 11.66% decline from 2022.
  • Zoetis total liabilities for 2022 were $10.522B, a 12.46% increase from 2021.
  
Zoetis Annual Total Liabilities
(Millions of US $)
2024 $9,467
2023 $9,295
2022 $10,522
2021 $9,356
2020 $9,836
2019 $8,837
2018 $8,592
2017 $6,800
2016 $6,150
2015 $6,822
2014 $5,251
2013 $5,596
2012 $2,221
2011 $1,975
2010 $0
Zoetis Quarterly Total Liabilities
(Millions of US $)
2024-12-31 $9,467
2024-09-30 $9,123
2024-06-30 $9,205
2024-03-31 $9,296
2023-12-31 $9,295
2023-09-30 $9,032
2023-06-30 $9,128
2023-03-31 $9,263
2022-12-31 $10,522
2022-09-30 $9,012
2022-06-30 $9,190
2022-03-31 $9,202
2021-12-31 $9,356
2021-09-30 $9,024
2021-06-30 $9,717
2021-03-31 $9,704
2020-12-31 $9,836
2020-09-30 $10,118
2020-06-30 $10,082
2020-03-31 $8,775
2019-12-31 $8,837
2019-09-30 $8,594
2019-06-30 $8,575
2019-03-31 $8,566
2018-12-31 $8,592
2018-09-30 $8,341
2018-06-30 $6,621
2018-03-31 $6,715
2017-12-31 $6,800
2017-09-30 $7,269
2017-06-30 $6,056
2017-03-31 $6,014
2016-12-31 $6,150
2016-09-30 $6,117
2016-06-30 $6,147
2016-03-31 $6,266
2015-12-31 $6,822
2015-09-30 $5,432
2015-06-30 $5,396
2015-03-31 $5,125
2014-12-31 $5,251
2014-09-30 $5,138
2014-06-30 $5,239
2014-03-31 $5,304
2013-12-31 $5,596
2013-09-30 $5,393
2013-06-30 $5,438
2013-03-31 $5,418
2012-12-31 $2,221
2012-09-30 $0
2012-06-30 $0
2012-03-31 $0
2011-12-31 $1,975
2010-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $66.334B $9.256B
Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $95.045B 37.51
Takeda Pharmaceutical (TAK) Japan $46.806B 10.36
Daiichi Sankyo, - (DSNKY) Japan $41.678B 25.40
Summit Therapeutics (SMMT) United States $18.154B 0.00
Sandoz Group AG (SDZNY) Switzerland $17.706B 0.00
Merck (MKKGY) Germany $17.202B 14.23
Astellas Pharma (ALPMY) Japan $16.920B 11.99
Shionogi (SGIOY) Japan $14.087B 0.00
United Therapeutics (UTHR) United States $12.788B 11.57
Neurocrine Biosciences (NBIX) United States $10.030B 30.82
IPSEN (IPSEY) France $8.640B 0.00
Orion OYJ (ORINY) Finland $7.957B 22.55
Madrigal Pharmaceuticals (MDGL) United States $6.661B 0.00
Stevanato Group S.p.A (STVN) Italy $6.620B 42.04
Corcept Therapeutics (CORT) United States $6.567B 50.19
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.813B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.547B 11.36
Grifols, S.A (GRFS) Spain $4.868B 0.00
Ionis Pharmaceuticals (IONS) United States $4.515B 0.00
Soleno Therapeutics (SLNO) United States $3.209B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.831B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.747B 11.15
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.281B 14.15
Recursion Pharmaceuticals (RXRX) United States $2.211B 0.00
Hypermarcas (HYPMY) Brazil $2.128B 8.40
NewAmsterdam Pharma (NAMS) Netherlands $1.794B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.638B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.546B 0.00
Guardian Pharmacy Services (GRDN) United States $1.526B 0.00
ARS Pharmaceuticals (SPRY) United States $1.460B 186.00
Evotec AG (EVO) Germany $1.278B 0.00
Indivior (INDV) United States $1.242B 5.40
Ocular Therapeutix (OCUL) United States $1.162B 0.00
Ardelyx (ARDX) United States $1.148B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.064B 43.06
Dyne Therapeutics (DYN) United States $0.928B 0.00
AleAnna (ANNA) United States $0.878B 0.00
Collegium Pharmaceutical (COLL) United States $0.868B 4.61
Harrow (HROW) United States $0.855B 0.00
Enliven Therapeutics (ELVN) United States $0.810B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.776B 0.00
Xencor (XNCR) United States $0.683B 0.00
Cronos Group (CRON) Canada $0.682B 0.00
Bioventus (BVS) United States $0.641B 16.64
Xeris Biopharma Holdings (XERS) United States $0.633B 0.00
KalVista Pharmaceuticals (KALV) United States $0.597B 0.00
Organogenesis (ORGO) United States $0.535B 0.00
Savara (SVRA) United States $0.520B 0.00
Akebia Therapeutics (AKBA) United States $0.487B 0.00
Relay Therapeutics (RLAY) United States $0.456B 0.00
Elite Pharmaceuticals (ELTP) United States $0.450B 0.00
USANA Health Sciences (USNA) United States $0.448B 9.13
Theravance Biopharma (TBPH) Cayman Islands $0.431B 0.00
Siga Technologies (SIGA) United States $0.428B 7.30
Tourmaline Bio (TRML) United States $0.411B 0.00
Verve Therapeutics (VERV) United States $0.408B 0.00
Zevra Therapeutics (ZVRA) United States $0.387B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.353B 0.00
Altimmune (ALT) United States $0.350B 0.00
Oruka Therapeutics (ORKA) United States $0.345B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.301B 17.93
Heron Therapeutics (HRTX) United States $0.280B 0.00
CytoDyn (CYDY) United States $0.251B 0.00
Aquestive Therapeutics (AQST) United States $0.248B 0.00
Avita Medical (RCEL) United States $0.243B 0.00
ProKidney (PROK) United States $0.231B 0.00
OmniAb (OABI) United States $0.219B 0.00
Nature's Sunshine Products (NATR) United States $0.218B 25.70
Esperion Therapeutics (ESPR) United States $0.188B 23.75
MediWound (MDWD) Israel $0.185B 0.00
Wellgistics Health (WGRX) United States $0.171B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.164B 0.00
Nanobiotix S.A (NBTX) France $0.155B 0.00
Journey Medical (DERM) United States $0.144B 0.00
Profound Medical (PROF) Canada $0.144B 0.00
Protara Therapeutics (TARA) United States $0.143B 0.00
4D Molecular Therapeutics (FDMT) United States $0.142B 0.00
Inhibikase Therapeutics (IKT) United States $0.141B 0.00
Regulus Therapeutics (RGLS) United States $0.136B 0.00
Aldeyra Therapeutics (ALDX) United States $0.131B 0.00
Korro Bio (KRRO) United States $0.131B 0.00
Lyell Immunopharma (LYEL) United States $0.128B 0.00
Aclaris Therapeutics (ACRS) United States $0.123B 0.00
Larimar Therapeutics (LRMR) United States $0.122B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Nektar Therapeutics (NKTR) United States $0.118B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.118B 36.33
Champions Oncology (CSBR) United States $0.110B 18.11
Enanta Pharmaceuticals (ENTA) United States $0.109B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.101B 0.00
OptiNose (OPTN) United States $0.093B 0.00
Lexeo Therapeutics (LXEO) United States $0.090B 0.00
Galectin Therapeutics (GALT) United States $0.087B 0.00
Arch Biopartners (ACHFF) Canada $0.084B 0.00
Cardiol Therapeutics (CRDL) Canada $0.083B 0.00
ESSA Pharma (EPIX) Canada $0.079B 0.00
VAXART, INC (VXRT) United States $0.078B 0.00
Context Therapeutics (CNTX) United States $0.076B 0.00
Telomir Pharmaceuticals (TELO) United States $0.074B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.074B 0.00
Unicycive Therapeutics (UNCY) United States $0.072B 0.00
Cassava Sciences (SAVA) United States $0.070B 0.00
Achieve Life Sciences (ACHV) Canada $0.069B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.066B 0.00
Vivani Medical (VANI) United States $0.063B 0.00
Fractyl Health (GUTS) United States $0.060B 0.00
Pyxis Oncology (PYXS) United States $0.059B 0.00
Assertio Holdings (ASRT) United States $0.058B 0.00
Metagenomi (MGX) United States $0.057B 0.00
Acrivon Therapeutics (ACRV) United States $0.057B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.056B 0.00
Nutriband (NTRB) United States $0.056B 0.00
Inotiv (NOTV) United States $0.055B 0.00
PMV Pharmaceuticals (PMVP) United States $0.053B 0.00
Gain Therapeutics (GANX) United States $0.050B 0.00
Avalo Therapeutics (AVTX) United States $0.047B 0.00
Century Therapeutics (IPSC) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.047B 0.00
Prelude Therapeutics (PRLD) United States $0.046B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.045B 0.00
Dominari Holdings (DOMH) United States $0.044B 0.00
ElectroCore (ECOR) United States $0.043B 0.00
Karyopharm Therapeutics (KPTI) United States $0.042B 0.00
Rafael Holdings (RFL) United States $0.042B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.037B 0.00
SCYNEXIS (SCYX) United States $0.035B 0.00
NRx Pharmaceuticals (NRXP) United States $0.033B 0.00
Surrozen (SRZN) United States $0.032B 0.00
FibroGen (FGEN) United States $0.029B 0.00
VYNE Therapeutics (VYNE) United States $0.028B 0.00
PolyPid (PYPD) Israel $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.026B 0.00
CASI Pharmaceuticals (CASI) China $0.024B 0.00
DURECT (DRRX) United States $0.023B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
Enlivex Therapeutics (ENLV) Israel $0.018B 0.00
Mannatech (MTEX) United States $0.018B 7.14
Natural Alternatives (NAII) United States $0.017B 0.00
Lipocine (LPCN) United States $0.016B 0.00
BioVie (BIVI) United States $0.016B 0.00
GlycoMimetics (GLYC) United States $0.014B 0.00
Mangoceuticals (MGRX) United States $0.013B 0.00
MEI Pharma (MEIP) United States $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.013B 0.00
Vivos Therapeutics (VVOS) United States $0.012B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.012B 0.00
ProPhase Labs (PRPH) United States $0.012B 0.00
TherapeuticsMD (TXMD) United States $0.012B 0.00
Plus Therapeutics (PSTV) United States $0.011B 0.00
Minerva Neurosciences (NERV) United States $0.011B 8.42
Scienture Holdings (SCNX) United States $0.011B 0.00
Incannex Healthcare (IXHL) Australia $0.011B 0.00
Traws Pharma (TRAW) United States $0.010B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Ernexa Therapeutics (ERNA) United States $0.010B 0.00
Relmada Therapeutics (RLMD) United States $0.010B 0.00
BioLineRx (BLRX) Israel $0.010B 0.00
Cosmos Health (COSM) United States $0.009B 0.00
Citius Pharmaceuticals (CTXR) United States $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 2.68
Nuvilex (PMCB) United States $0.008B 0.00
Talphera (TLPH) United States $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Lyra Therapeutics (LYRA) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.005B 0.00
Klotho Neurosciences (KLTO) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.004B 0.00
Conduit Pharmaceuticals (CDT) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Petros Pharmaceuticals (PTPI) United States $0.002B 0.00
CERo Therapeutics Holdings (CERO) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Heatwurx (PCSA) United States $0.001B 0.00
SHINECO (SISI) China $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00